Alphatec (NASDAQ:ATEC) Rating Reiterated by Needham & Company LLC

Alphatec (NASDAQ:ATEC – Get Rating)‘s stock had its “buy” rating restated by Needham & Company LLC in a research report issued on Monday, Benzinga reports. They currently have a $18.00 price objective on the medical technology company’s stock. Needham & Company LLC’s price target would indicate a potential upside of 14.87% from the company’s previous […]

Related Keywords

Jamesll Tullis , ,Securities Exchange Commission ,Leverage Partners Absolute Return Fund ,Alphatec Company Profile ,First Light Asset Management ,Waypoint Capital Advisors ,Alphatec Holdings Inc ,Jump Financial ,Morgan Stanley ,Needham Company ,Get Rating ,Lake Street Capital ,Exchange Commission ,Director James ,Light Asset Management ,Capital Advisors ,Global Management ,Alphatec Daily ,Alphatec ,Nasdaq Atec ,Zatec ,Medical ,02081g10 ,Reiterated Rating ,Needham Company Llc ,